Please login to the form below

Not currently logged in
Email:
Password:

divestments

This page shows the latest divestments news and features for those working in and with pharma, biotech and healthcare.

Liver cancer failure dents Opdivo potential by $1bn, says analyst

Liver cancer failure dents Opdivo potential by $1bn, says analyst

Add in the news that the Otezla divestment and other financial regulatory deliberations will extend the closure of the merger with Celgene by several months -potentially into next year – and

Latest news

More from news
Approximately 2 fully matching, plus 68 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Teva/Alder Biopharmaceuticals patent settlement. We have featured Teva in Deal Watch over the last few months but focused more on the company's divestment activities to tackle its debt

  • Deal Watch February 2017 Deal Watch February 2017

    The largest of these was Perrigo's divestment to Royalty Pharma of its royalty stream from Biogen's global sales of Tysabri (natalizumab), the multiple sclerosis antibody originally developed by Elan, ... Sanofi's $88.3m deal with Ipsen covers the

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    Out-partnering deals included the $1.1bn licence to LEO for tralokinumab in skin diseases and the $1bn divestment to Pfizer of its late-stage small molecule anti-infective business. ... will contribute to a decline in the number of M&A deals over $5bn,

  • Deal Watch January 2017 Deal Watch January 2017

    1, 600. Valeant. L'Oreal. Divestment. CeraVe AcneFree AMBI. 1, 300. Forward Pharma. ... 960. Valeant. Sanpower Group. Divestment. Dendreon equity interest. 820. Delinia. Celgene.

  • Deal Watch October 2016 Deal Watch October 2016

    They must have been working eight days a week! Core therapy area acquisitions and non-core divestments are changing the shape of AstraZeneca. ... The Month of Divestments – We Can Work It Out. At least AstraZeneca are making a proactive approach to

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics